Cannabis Science Issues Second Quarter Update Looking Forward to More Quarterly Growth and Progress Reports with More New and Exciting Revenue Developments Coming Soon

IRVINE, CA–(Marketwired – Aug 7, 2017) – Cannabis Science, Inc. ( OTC PINK : CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to update its shareholders on the Company’s second quarter growth and progress. Cannabis Science has made considerable gains in its endeavors…

General Cannabis Announces 2017 Second Quarter Results

DENVER, Aug. 07, 2017 (GLOBE NEWSWIRE) — General Cannabis Corp (CANN), the comprehensive national resource to the regulated cannabis industry, today announced financial results for the quarter ended June 30, 2017. For the three months ended June 30, 2017, we reported our highest quarterly revenues on record of approximately…

Cannabis to Treat Autism | Cannabis Culture

CANNABIS CULTURE- While autism is not yet widely considered a condition for which medical marijuana can be prescribed, doctors have noted cannabis’ therapeutic benefits to relieve autism symptoms. That is why marijuana is now respected by legions of doctors and scientists who understand the positive impacts that marijuana has on…